The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), Boston Scientific Corp (NYSE:BSX), Humana (NYSE:HUM), McKesson Corp (NYSE:MCK).
The investment seeks long-term capital appreciation.
The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities.
The average market capitalization across the Alger Health Sciences A MF is 82.02B. The market cap for tickers in the group ranges from 61.83B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is MCK at 61.83B.
The average weekly volume growth across all stocks in the Alger Health Sciences A MF was -60%. For the same stocks of the MF, the average monthly volume growth was -68% and the average quarterly volume growth was -64%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 58
P/E Growth Rating: 57
Price Growth Rating: 48
SMR Rating: 62
Profit Risk Rating: 50
Seasonality Score: -1 (-100 ... +100)